Correlation Between Aptose Biosciences and Bristol Myers

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aptose Biosciences and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aptose Biosciences and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aptose Biosciences and Bristol Myers Squibb, you can compare the effects of market volatilities on Aptose Biosciences and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aptose Biosciences with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aptose Biosciences and Bristol Myers.

Diversification Opportunities for Aptose Biosciences and Bristol Myers

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Aptose and Bristol is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Aptose Biosciences and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and Aptose Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aptose Biosciences are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of Aptose Biosciences i.e., Aptose Biosciences and Bristol Myers go up and down completely randomly.

Pair Corralation between Aptose Biosciences and Bristol Myers

Given the investment horizon of 90 days Aptose Biosciences is expected to under-perform the Bristol Myers. In addition to that, Aptose Biosciences is 3.4 times more volatile than Bristol Myers Squibb. It trades about -0.12 of its total potential returns per unit of risk. Bristol Myers Squibb is currently generating about 0.05 per unit of volatility. If you would invest  4,762  in Bristol Myers Squibb on November 9, 2024 and sell it today you would earn a total of  980.00  from holding Bristol Myers Squibb or generate 20.58% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Aptose Biosciences  vs.  Bristol Myers Squibb

 Performance 
       Timeline  
Aptose Biosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Aptose Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Bristol Myers Squibb 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Over the last 90 days Bristol Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Bristol Myers is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Aptose Biosciences and Bristol Myers Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aptose Biosciences and Bristol Myers

The main advantage of trading using opposite Aptose Biosciences and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aptose Biosciences position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.
The idea behind Aptose Biosciences and Bristol Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Transaction History
View history of all your transactions and understand their impact on performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes